Skip to main content
SpringerLink
Log in

Diabetic ketosis/ketoacidosis with SGLT2 inhibitors

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Limenta M, et al. Adverse Drug Reaction Profile of SGLT2 Inhibitor-Associated Diabetic Ketosis/Ketoacidosis in Singapore and their Precipitating Factors. Clinical Drug Investigation : 7 May 2019. Available from: URL: http://doi.org/10.1007/s40261-019-00794-5

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Diabetic ketosis/ketoacidosis with SGLT2 inhibitors. Reactions Weekly 1754, 5 (2019). https://doi.org/10.1007/s40278-019-62238-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-019-62238-3

Search

Navigation